ClinicalTrials.gg
CompletedNCT03639233YESS!Updated Oct 30, 2019

Youth Epilepsy and Successful Self-Management Intervention

An interventional study of YESS! in Epilepsy, sponsored by University of Minnesota. Completed at 1 site in United States. Open to participants aged 13 Years to 19 Years. Per ClinicalTrials.gov, last updated 2019-10-30.

Sponsored by University of Minnesota · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Not applicable
Ages
13 Years to 19 Years
Sex
All
01

Study summary

This study is designed as a pilot test of the YESS! web-based intervention for adolescents with epilepsy. One hundred twenty participants will be given access to the intervention for a period of eight weeks. The investigators are testing the feasibility and acceptability of the the study procedures, measures and of the intervention itself. The study also evaluats the potential for impact on the users.

Read the detailed description

YESS! is a web-based self management program developed to enhance the motivation and skills of youth with epilepsy.

This clinical trial uses a pre-test, post-test design where all consenting participants are given access to the intervention.

02

Conditions studied

  • Epilepsy

Browse trials for

03

In context

Epilepsy

1,842 studies on the registry are indexed under Epilepsy; 423 are open to participants now.

This study's enrollment of 120 is above the median of 50 across 1,228 interventional studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,210 studies on the registry; 195 are open to participants now.

Of its 133 completed or terminated interventional studies of FDA-regulated products, 92 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age as above
  • Epilepsy diagnosed by a physician
  • Currently taking anti-seizure medications or use device
  • Ability to understand and respond to questions about health and epilepsy
  • Ability to utilize an internet based intervention website

Exclusion criteria

Exclusion Criteria:

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Other
    Arm 1

    Intervention access

    Behavioral: YESS!

Interventions

  • BehavioralYESS!

    Web based self-management education

06

What researchers measure

Primary outcomes

  1. Feasibility of recruiting and enrollment procedures and

    Measure the extent to which the recruitment and enrollment procedures meet the study aims in terms of number of participants log in to the intervention

    Time frame: 8 weeks after getting access to the web intervention

  2. Acceptability of intervention website users

    and the extent to which users (study subjects) find the intervention easy to use, enjoyable to use, useful, engaging. Acceptability is a multifaceted and complex concept. As such it it is best examined as a system of interacting attributes.

    Time frame: 8 weeks after getting access to the web intervention

Secondary outcomes

  1. Participant Well-being

    measures of overall well-being (EPOCH wellbeing meausre)

    Time frame: 8 weeks after getting access to the web intervention and 8 weeks after that.

  2. Participant Quality of Life

    measure quality of life in epilepsy (QoLiE-10)

    Time frame: 8 weeks after getting access to the web intervention and 8 weeks after that.

  3. self-management behavior profile

    measure the frequency of self management behaviors (taking medications, making clinic appointments, speaking with doctor/nurse/teacher) using a measure developed for this study

    Time frame: 8 weeks after getting access to the web intervention and 8 weeks after that.

  4. self-management motivation profile

    measure the motivations (autonomous and extrinsic reasons for engaging in self management) using an adapted version of a standardized measure of motivation

    Time frame: 8 weeks after getting access to the web intervention and 8 weeks after that.

07

Study locations

1 site
  • University of Minnesota
    Minneapolis, Minnesota 55455, United States
08

References and documents

Individual participant data

Plan to share: Yes — YESS! is a member of the Managing Epilepsy Well (MEW) and the associated shared database of deidentified participant records

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03639233
Responsible party
Sponsor
First posted
Aug 21, 2018
Start date
Oct 1, 2018
Primary completion
Sep 1, 2019
Completion
Sep 1, 2019
Last update
Oct 30, 2019

Study contacts

Peter Scal, MD MPH
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion